This edition of By the Numbers plots the rise of biology-centric autism grants, a dearth of West African autism research and the lack of racial data in intervention studies.
Only a quarter of more than 1,000 autism intervention studies published since 1990 report on participants’ races and ethnicities, and just one included a Native American participant.
The connection is likely mediated by environmental, not genetic, factors, according to a new study.
In this edition of By the Numbers, we discuss geographic disparities in access to behavior therapy, autism incidence among the privately or publicly insured and the rarity of criminal charges against autistic people in New Zealand.
Spectrum’s Autism Drug Trial Tracker provides interactive, curated information about hundreds of clinical trials for autism and related conditions.
Explore hundreds of clinical trials with our interactive tool.
Learn how to use the Autism Drug Trial Tracker, with specific examples and detailed explanations for each data column.
In this edition of By the Numbers, we discuss how translation alters a screening tool’s accuracy, the closing racial gap in autism prevalence numbers, and the preponderance of autism without intellectual disability.
Autism diagnoses in the United States now precede developmental services and interventions, according to a new study.
This edition of By the Numbers logs the continued underrepresentation of Black speakers at neuroscience meetings, mildly-effective cognitive behavioral therapy and early autism diagnoses.